SummaryRMgm-405
|
Successful modification | The parasite was generated by the genetic modification |
The mutant contains the following genetic modification(s) | Gene disruption |
Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 21379566 |
MR4 number | |
top of page | |
Parent parasite used to introduce the genetic modification | |
Rodent Malaria Parasite | P. yoelii |
Parent strain/line | P. y. yoelii YM |
Name parent line/clone | Not applicable |
Other information parent line | P. yoelii YM is a virulent strain of P. yoelii |
top of page | |
The mutant parasite was generated by | |
Name PI/Researcher | S.A. Ogun; A.A. Holder |
Name Group/Department | Division of Parasitology |
Name Institute | MRC National Institute for Medical Research |
City | London |
Country | UK |
top of page | |
Name of the mutant parasite | |
RMgm number | RMgm-405 |
Principal name | PY01365-KO |
Alternative name | |
Standardized name | |
Is the mutant parasite cloned after genetic modification | Yes |
top of page | |
Phenotype | |
Asexual blood stage | Not different from wild type |
Gametocyte/Gamete | Not tested |
Fertilization and ookinete | Not tested |
Oocyst | Not tested |
Sporozoite | Not tested |
Liver stage | Not tested |
Additional remarks phenotype | Mutant/mutation The pehenotype of an independent mutant lacking expression of PY01365 (RMgm-615) has been reported. The phenotype of this mutant is different from the phenotype reported in this study (see 'Additional Information' below). Additional information The Py235 family of proteins belongs to the reticulocyte binding-like (RBL) super family, with homology with the reticulocyte binding protein RBP-1 (PVX_098585) and RBP-2 (PVX_121920) of P. vivax. P. falciparum contains a small group of genes coding for proteins with similarities to Py235 and PvRBP, the PfRH family (for example see the reticulocyte binding protein 2 homologue a (PF13_0198) and the reticulocyte binding protein 2 homologue b (MAL13P1.176)). In P. falciparum, the RH protein genes are under epigenetic control and expression correlates with binding to distinct erythrocyte receptors and specific invasion pathways, whereas in P. yoelii YM all the genes are expressed and deletion of one does not result in upregulation of another. Based on these results it is proposed that simultaneous expression of multiple Py235 ligands enables invasion of a wide range of host erythrocytes even in the presence of antibodies to one or more of the proteins and that this functional redundancy at the protein level gives the parasite phenotypic plasticity in the absence of differences in gene expression. In an independent study the phenotype has been analysed from an independent P. yoelii mutant lacking expression of PY01365 (see RMgm-615). This mutant showed a different (delayed) course of parasitemia in BALB/c mice and BALB/c mice showed a delayed death from infection. Moreover data is presented indicating that disruption of PY01365 leads to a change in the overall transcription pattern of different members of Py235. Other mutants |
top of page | |||||||||||||||||||||||||
Details of the target gene | |||||||||||||||||||||||||
Gene Model of Rodent Parasite | PY17X_1468100 | ||||||||||||||||||||||||
Gene Model P. falciparum ortholog | Not available | ||||||||||||||||||||||||
Gene product | rhoptry protein | ||||||||||||||||||||||||
Gene product: Alternative name | 235EBP-1; Py235EBP-1; erythrocyte binding protein 1 | ||||||||||||||||||||||||
top of page | |||||||||||||||||||||||||
Details of the genetic modification | |||||||||||||||||||||||||
Inducable system used | No | ||||||||||||||||||||||||
Additional remarks inducable system | |||||||||||||||||||||||||
Type of plasmid/construct used | Plasmid double cross-over | ||||||||||||||||||||||||
PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||
Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||
Plasmid/construct map | |||||||||||||||||||||||||
Plasmid/construct sequence |
gtggcacttttcggggaaatgtgcgcggaacccctatttgtttatttttctaaatacattcaaatatgtatccgctcatgagacaataaccctgataaatgcttcaataatattgaaaaaggaagagtatgagtattcaacatttccgtgtcgcccttattcccttttttgcggcattttgccttcctgtttttgctcacccagaaacgctggtgaaagtaaaagatgctgaagatcagttgggtgcacgagtgggttacatcgaactggatctcaacagcggtaagatccttgagagttttcgccccgaagaacgttttccaatgatgagcacttttaaagttctgctatgtggcgcggtattatcccgtattgacgccgggcaagagcaactcggtcgccgcatacactattctcagaatgacttggttgagtactcaccagtcacagaaaagcatcttacggatggcatgacagtaagagaattatgcagtgctgccataaccatgagtgataacactgcggccaacttacttctgacaacgatcggaggaccgaaggagctaaccgcttttttgcacaacatgggggatcatgtaactcgccttgatcgttgggaaccggagctgaatgaagccataccaaacgacgagcgtgacaccacgatgcctgtagcaatggcaacaacgttgcgcaaactattaactggcgaactacttactctagcttcccggcaacaattaatagactggatggaggcggataaagttgcaggaccacttctgcgctcggcccttccggctggctggtttattgctgataaatctggagccggtgagcgtgggtctcgcggtatcattgcagcactggggccagatggtaagccctcccgtatcgtagttatctacacgacggggagtcaggcaactatggatgaacgaaatagacagatcgctgagataggtgcctcactgattaagcattggtaactgtcagaccaagtttactcatatatactttagattgatttaaaacttcatttttaatttaaaaggatctaggtgaagatcctttttgataatctcatgaccaaaatcccttaacgtgagttttcgttccactgagcgtcagaccccgtagaaaagatcaaaggatcttcttgagatcctttttttctgcgcgtaatctgctgcttgcaaacaaaaaaaccaccgctaccagcggtggtttgtttgccggatcaagagctaccaactctttttccgaaggtaactggcttcagcagagcgcagataccaaatactgtccttctagtgtagccgtagttaggccaccacttcaagaactctgtagcaccgcctacatacctcgctctgctaatcctgttaccagtggctgctgccagtggcgataagtcgtgtcttaccgggttggactcaagacgatagttaccggataaggcgcagcggtcgggctgaacggggggttcgtgcacacagcccagcttggagcgaacgacctacaccgaactgagatacctacagcgtgagctatgagaaagcgccacgcttcccgaagggagaaaggcggacaggtatccggtaagcggcagggtcggaacaggagagcgcacgagggagcttccagggggaaacgcctggtatctttatagtcctgtcgggtttcgccacctctgacttgagcgtcgatttttgtgatgctcgtcaggggggcggagcctatggaaaaacgccagcaacgcggcctttttacggttcctggccttttgctggccttttgctcacatgttctttcctgcgttatcccctgattctgtggataaccgtattaccgcctttgagtgagctgataccgctcgccgcagccgaacgaccgagcgcagcgagtcagtgagcgaggaagcggaagagcgcccaatacgcaaaccgcctctccccgcgcgttggccgattcattaatgcagctggcacgacaggtttcccgactggaaagcgggcagtgagcgcaacgcaattaatgtgagttagctcactcattaggcaccccaggctttacactttatgcttccggctcgtatgttgtgtggaattgtgagcggataacaatttcacacaggaaacagctatgaccatgattacgccaagcgcgcaattaaccctcactaaagggaacaaaagctgggtaccgggccccccctcgaggtcgacggtatcgataagcttgcatgcctgcaggtcaacaataaataataaataaatattgtggaaataaaataacatataattatttttaatacattgatttcccttttatttttttaaatttcattgatataaaaatatataataataacatatatgatttcaaattaatcttttcaaaaatggtgtttatttttgtatgtttgtgtatgaattaatcacataacacatctattaaattgagttggtaatatagacacaaataaatatatatatttttatagcttaaaagtgtgttatgaatattttaagcatattttctttttctttggattgtgtaaaatgaactcatataatgcgtttttttgtttttgttattttgtcattttgttattttgctattttatggattaatttttgtttataaaatgggaaataattttaacatatttaaataaatggagaaaaaatataaaataattataaaaaaaagttaatacacattttttcctgttatagaccttatatttatttatccatatatatatatatatatatatatatatatatatacataccaagtgaattaagaggaaagctaatttattattcagaataatatatgaactatatataatttttattattttggtgtatattaatctgtctatatgcatacatgcaataatttatcgacttatatatcaaataacataaaatagaagtgttttaaattatggatatatgctcaatattcattttttttaataagttagctatatttaaattatacattttatatatggtctcttttttttttaaatattatttaagtgatcatgaaaatataaataatttttttttatttaatatccttttgcttgcatgtggtaaatggaaatttggatgtgttttgaargttcggatatagttgtatggacatataatatattttgtgaaaaattggttttatgtttatacttatgccaatactttttgagtaaaacaaagcaagtgcttataaataattaaagccaattttataatatatatttttttatttaatttgaatttagtagtataattttttatggtaagtgctcaaagagagttgcttataaagtatggtttgtttctttttcgccattttgaattacacattaaaaatatatagatacatatattataatatgaaatcattaataatttagggaaattctacaaatttaaaaacgaataaaataattgtttttcatcatgccataacacaatattgatatatacatgtacaaacattttttttatttggaaaatataaattatataaaaaaaaatgtatagtatacaaaatgagcatattcacacggggtggacgttcattttttcatttttcccctgttttttatgagtatatgataaaattttatgaacatttacacaaaatgaaaatggatatataggaaaaatggagcggtatttcatttatctttgattgtcatttggatattatattaccytgggtaggcaattaaaaatgttaaataacaatttaaggaaattatattttatatattaaaattaacactgtattatatgattcgcttataaaagccactctttccccatgcaaagctgtttaatatcaattttaacaaattacacacatgttaatatatttatatatataatttatatatttataatttatatatttatatttttattatttatatatttattatttattgtgtgtgtcaattcgggtaggatatacctcttttttattgtttaaagcgatttgtattctaaaatataaagratttgaaaaagagaaagatagaatatgatcccatcatatatagccctataatttttatttagcagcgaattaatttttctattaagtttatgtgtaattaaaataacggaatatatataatacaataaaaaagtgcataaattaaaattttttcaattaaatttttttttttaaggggttatataatattaaatatataaaatacgattatatatttttgctacaattttttatattaagatataaatagtaaataaatggtattatatggcatgtaatatataaattttttccaatttttattttatatacacttttcctttttttgtcataaaacttaaacaatttacacattcattttaaaaattgactatttgtttcaacattttttgagtttccgttttataatagtattttcatttgtatattgcttatatatataaatacacacctaaatgttacaaaggatcaatgcataaaccggtgtgtctggtcgtcgcgatgacccccaagaggggcatcggcatcaacaacggcctcccgtggccccacttgaccacagatttcaaacacttttctcgtgtgacaaaaacgacgcccgaagaagccagtcgcctgaacgggtggcttcccaggaaatttgcaaagacgggcgactctggacttccctctccatcagtcggcaagagattcaacgccgttgtcatgggacggaaaacctgggaaagcatgcctcgaaagtttagacccctcgtggacagattgaacatcgtcgtttcctcttccctcaaagaagaagacattgcggcggagaagcctcaagctgaaggccagcagcgcgtccgagtctgtgcttcactcccagcagctctcagccttctggaggaagagtacaaggattctgtcgaccagatttttgtcgtgggaggagcgggactgtacgaggcagcgctgtctctgggcgttgcctctcacctgtacatcacgcgtgtagcccgcgagtttccgtgcgacgttttcttccctgcgttccccggagatgacattctttcaaacaaatcaactgctgcgcaggctgcagctcctgccgagtctgtgttcgttcccttttgtccggagctcggaagagagaaggacaatgaagcgacgtatcgacccatcttcatttccaagaccttctcagacaacggggttccctacgactttgtggttctcgagaagagaaggaagactgacgacgcagccactgcggaaccgagcaacgcaatgagctccttgacgtccacgagggagacaactcccgtgcacgggttgcaggctccttcttcggccgcagccattgccccggtgttggcgtggatggacgaagaagaccggaaaaaacgcgagcaaaaggaactgattcgggccgttccgcatgttcactttagaggccatgaagagttccagtaccttgatctcattgccgacattattaacaatggaaggacaatggatgaccgaacgggcgttggtgtcatctccaaattcggctgcactatgcgctactcgctggatcaggcctttccacttctcaccacaaagcgtgtgttctggaaaggggtcctcgaagagttgctgtggttcattcgcggcgacacgaacgcaaaccatctttctgagaagggcgtgaagatctgggacaagaatgtgacacgcgagttcctcgattcgcgcaatctcccccaccgagaggtcggagacatcggcccgggctacggcttccagtggagacacttcggcgcggcatacaaagacatgcacacagactacacagggcagggcgtcgaccagctgaagaatgtgatccagatgctgagaacgaatccaacagatcgtcgcatgctcatgactgcctggaatcctgcagcgctggacgaaatggcgctgccgccttgtcacttgttgtgccagttctacgtgaacgaccagaaggagctgtcgtgcatcatgtatcagcggtcgtgcgatgtcggcctcggcgtccccttcaacatcgcttcctattcgcttttgacgctcatggttgcacacgtctgcaacctaaaacctaaggagttcattcacttcatggggaacacgcatgtctacacgaaccatgtcgaggctttaaaagagcagctgcggagagaaccgagaccgttccccattgtgaacatcctcaacaaggaacgcatcaaggaaatcgacgatttcaccgccgaggattttgaggtcgtgggctacgtcccgcacggacgaatccagatggagatggctgtctagcggaaatacagaagctagctttgatcccgtttttcttacttatatatttataccaattgattgtatttataactgtaaaaatgtgtatgttgtgtgcatatttttttttgtgcatgcacatgcatgtaaatagctaaaattatgaacattttattttttgttcagaaaaaaaaaactttacacacataaaatggctagtatgaatagccatattttatataaattaaatcctatgaatttatgaccatattaaaaatttagatatttatggaacataatatgtttgaaacaataagacaaaattattattattattattatttttactgttataattatgttgtctcttcaatgattcataaatagttggacttgatttttaaaatgtttataatatgattagcatagttaaataaaaaaagttgaaaaattaaaaaaaaacatataaacacaaatgatgttttttccttcaatttcgatatcgaattcctgcagcccgggggatccactagttctagagcggccgccaccgcggtggagctccaattcgccctatagtgagtcgtattacgcgcgctcactggccgtcgttttacaacgtcgtgactgggaaaaccctggcgttacccaacttaatcgccttgcagcacatccccctttcgccagctggcgtaatagcgaagaggcccgcaccgatcgcccttcccaacagttgcgcagcctgaatggcgaatgggacgcgccctgtagcggcgcattaagcgcggcgggtgtggtggttacgcgcagcgtgaccgctacacttgccagcgccctagcgcccgctcctttcgctttcttcccttcctttctcgccacgttcgccggctttccccgtcaagctctaaatcgggggctccctttagggttccgatttagtgctttacggcacctcgaccccaaaaaacttgattagggtgatggttcacgtagtgggccatcgccctgatagacggtttttcgccctttgacgttggagtccacgttctttaatagtggactcttgttccaaactggaacaacactcaaccctatctcggtctattcttttgatttataagggattttgccgatttcggcctattggttaaaaaatgagctgatttaacaaaaatttaacgcgaattttaacaaaatattaacgcttacaatttag
| ||||||||||||||||||||||||
Restriction sites to linearize plasmid | ApaI, XbaI | ||||||||||||||||||||||||
Partial or complete disruption of the gene | Complete | ||||||||||||||||||||||||
Additional remarks partial/complete disruption | |||||||||||||||||||||||||
Selectable marker used to select the mutant parasite | tgdhfr | ||||||||||||||||||||||||
Promoter of the selectable marker | pbdhfr | ||||||||||||||||||||||||
Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||
Selection (negative) procedure | No | ||||||||||||||||||||||||
Additional remarks genetic modification | |||||||||||||||||||||||||
Additional remarks selection procedure | |||||||||||||||||||||||||
Primer information: Primers used for amplification of the target sequences
Primer information: Primers used for amplification of the target sequences
| |||||||||||||||||||||||||
top of page |